Syntax is designed to require less than 15 minutes of hands-on setup and synthesize DNA in as little as six hours, producing 96 ready-to-use oligos in parallel, according to the company. Ten companies and organizations that installed Syntax in their labs will provide usability feedback to DNA Script during the final evaluation, which follows an earlier evaluation by more than 30 companies.

In a separate development, DNA Script has partnered with GE Research and Moderna to use its technology as part of the U.S. Defense Advanced Research Projects Agency's Nucleic Acids On-Demand World-Wide Program.

DNA Script, Moderna to develop on-demand vaccines, therapeutics
DNA Script and Moderna have announced a partnership to develop on-demand vaccines and therapeutics as part of the U.S. Defense Advanced Research Projects...

Inscripta ships benchtop CRISPR platform, raises $150M
Inscripta has shipped its first Onyx platform for benchtop genome engineering and also closed $150 million in financing.

Bruker launches FT-NMR benchtop spectrometer
Bruker has unveiled its permanent-magnet Fourier 80 system, an 80-MHz Fourier transform nuclear magnetic resonance (FT-NMR) benchtop spectrometer for...

Beckman Coulter launches new benchtop cell sorter
Beckman Coulter Life Sciences has launched its Cytoflex SRT benchtop cell sorter that features expanded laser and color options.

Benchtop capillary electrophoresis opens new doors for sample identification
Sample identification and verification is essential to research that interrogates and compares specific regions of the human genome, called short tandem...